The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix

Reproductive BioMedicine Online

Volumn 6, Issue 4, 2003, Pages 421-426

  Tavaniotou, Asiminia ^a   Albano, Carola ^a   Van Steirteghem, André ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

Cetrorelix; Clomiphene citrate; GnRH antagonist; In vitro fertilization; Luteinizing hormone

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; METAPHASE; OOCYTE; OVARY FOLLICLE DEVELOPMENT; PREGNANCY RATE;

EID: 0037561016     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62161-X     Document Type: Article

References (25)

1. Adashi EY 1984 Clomiphene citrate: mechanism(s) and sitet(s) of action - a hypothesis revisited. Fertility and Sterility 42, 331-34
2. Adashi EY, Rock JA, Sapp KC et al. 1979 Gestational outcome of clomiphene-related conceptions. Fertility and Sterility 31, 620-626.
3. Albano C, Smitz J, Camus M et al. 1997 Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertility and Sterility 67, 917-922.
4. Albano C, Felberbaum RE, Smitz J et al. 2000 Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Human Reproduction 15, 526-531.
5. Al-Inany H, Aboulghar M 2002 GnRH antagonist in assisted reproduction: a Cochrane review. Human Reproduction 17, 874-885.
6. Craft I, Gorgy A, Hill J et al. 1999 Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Human Reproduction 14, 2959-2962.
7. Dickey RP, Taylor SN, Curole DN et al. 1996 Incidence of spontaneous abortion in clomiphene pregnancies. Human Reproduction 11, 2623-2628.
8. Diedrich K, Felberbaum R 1998 New approaches to ovarian stimulation. Human Reproduction 13 (suppl. 3), 1-13, discussion 14-17.
9. Engel JB, Felberbaum RE, Eilers W et al. 2002a Clomiphene-induced LH surges and cetrorelix. Reproductive BioMedicine Online 5, 109-111.
10. Engel JB, Ludwig M, Felberbaum R et al. 2002b Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? Human Reproduction 17, 2022-2026.
11. Hall JE, Brodie TD, Badger TM et al. 1988 Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. Journal of Clinical Endocrinology and Metabolism 67, 524-531.
12. Howles CM, Macnamee MC, Edwards RG et al. 1986 Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. The Lancet 2, 521-522.
13. Judd SJ, Alderman J, Bowden J et al. 1987 Evidence against the involvement of opiate neurons in mediating the effect of clomiphene citrate on gonadotropin-releasing hormone neurons. Fertility and Sterility 47, 574-577.
14. Maruncic M, Casper RF 1987 The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women. Journal of Clinical Endocrinology and Metabolism 64, 148-152.
15. Nikolettos N, Al-Hasani S, Felberbaum R 2001 Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. European Journal of Obstetrics Gynecology and Reproductive Biology 97, 202-207.
16. Quigley MM 1984 The use of ovulation-inducing agents in in-vitro fertilization. Clinical Obstetrics and Gynecology 27, 983-991.
17. Reissmann T, Schally AV, Bouchard P et al. 2000 The LHRH antagonist Cetrorelix: a review. Human Reproduction Update 6, 323-331.
18. Ronen J, Bosschieter J, Wiswedel K et al. 1988 Ovulation induction for in vitro fertilisation using clomiphene citrate and low-dose human menopausal gonadotrophin. International Journal of Fertility 33, 120-122.
19. Seibel MM 1995 Toward reducing risks and costs of egg donation: a preliminary report. Fertility and Sterility 64, 199-201.
20. Seibel MM, Smith DM 1989 The effect of clomiphene citrate on human preovulatory oocyte maturation in vivo. Journal of In Vitro Fertilization and Embryo Transfer 6, 3-6.
21. Shoham Z, Borenstein R, Lunenfeld B et al. 1990 Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clinical Endocrinology (Oxford) 33, 271-278.
22. Soules MR, Steiner R, Clifton D et al. 1984 Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. Journal of Clinical Endocrinology and Metabolism 58, 378-383.
23. Stanger JD, Yovich JL 1985 Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. British Journal of Obstetrics and Gynaecology 92, 385-393.
24. Tavaniotou A, Albano C, Smitz J et al. 2001 Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. Human Reproduction 16, 663-667.
25. Tavaniotou A, Albano C, Smitz J et al. 2002 Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. Fertility and Sterility 77, 733-737.